Matches in SemOpenAlex for { <https://semopenalex.org/work/W4291111105> ?p ?o ?g. }
- W4291111105 endingPage "55" @default.
- W4291111105 startingPage "43" @default.
- W4291111105 abstract "This study identifies promising potential of a novel and safer nanocombination of bovine milk lactoperoxidase (LPO) and lactoferrin (LF) to target breast cancer in vitro and in adult female albino rat model. Favorable selective anticancer effects of the prepared nanocombination were observed, in a dose-dependent manner, against both MCF-7 and MDA cell lines, sparing normal HFB-4 cells. The administration of LPO + LFNPs markedly improved the induced-breast cancer disorders, prolonged survival and reduced the values of serum TNF-α, IL1β, CD4+, ALAT, ASAT, urea, creatinine, cholesterol and triglycerides with remarkable elevation in mammary SOD and GPx activity and GSH level. Moreover, the histopathological findings showed that LPO + LFNPs succeeded in prevention of mammary gland tumorigenesis. Superior efficacy of LPO + LFNPs was observed against pro-inflammatory cytokines through their anti-inflammatory and immunomodulatory properties. The treatment of LPO + LFNPs more significantly modulated the apoptosis and enhanced the expression of cell cycle regulator genes, which demonstrates a successful tumor therapy in vitro and in vivo. Therefore, this study provided evidence that the chemo-preventive feature of LPO + LFNPs may offer a novel alternative therapy for the treatment of breast cancer through enhances apoptosis pathway, improvement of immune response, reduction of inflammation and restoration of the impaired oxidative stress." @default.
- W4291111105 created "2022-08-13" @default.
- W4291111105 creator A5004876774 @default.
- W4291111105 creator A5013392061 @default.
- W4291111105 creator A5050355037 @default.
- W4291111105 creator A5052056925 @default.
- W4291111105 creator A5076807685 @default.
- W4291111105 creator A5078361080 @default.
- W4291111105 creator A5080029717 @default.
- W4291111105 date "2022-11-01" @default.
- W4291111105 modified "2023-10-16" @default.
- W4291111105 title "Therapeutic efficacy of Nano-formulation of lactoperoxidase and lactoferrin via promoting immunomodulatory and apoptotic effects" @default.
- W4291111105 cites W1564461227 @default.
- W4291111105 cites W1583514903 @default.
- W4291111105 cites W1966926851 @default.
- W4291111105 cites W1981152263 @default.
- W4291111105 cites W1985863037 @default.
- W4291111105 cites W1994193901 @default.
- W4291111105 cites W1998271063 @default.
- W4291111105 cites W1998891209 @default.
- W4291111105 cites W2006208579 @default.
- W4291111105 cites W2007720419 @default.
- W4291111105 cites W2011077759 @default.
- W4291111105 cites W2019022416 @default.
- W4291111105 cites W2021822715 @default.
- W4291111105 cites W2028944116 @default.
- W4291111105 cites W204546040 @default.
- W4291111105 cites W2048270768 @default.
- W4291111105 cites W2073502524 @default.
- W4291111105 cites W2087918291 @default.
- W4291111105 cites W2088542277 @default.
- W4291111105 cites W2114990679 @default.
- W4291111105 cites W2119393905 @default.
- W4291111105 cites W2119955771 @default.
- W4291111105 cites W2139762494 @default.
- W4291111105 cites W2155730420 @default.
- W4291111105 cites W2160135312 @default.
- W4291111105 cites W2164904069 @default.
- W4291111105 cites W2169909652 @default.
- W4291111105 cites W2233231835 @default.
- W4291111105 cites W2233672061 @default.
- W4291111105 cites W2269332562 @default.
- W4291111105 cites W2282811213 @default.
- W4291111105 cites W2289143627 @default.
- W4291111105 cites W2313365551 @default.
- W4291111105 cites W2346094740 @default.
- W4291111105 cites W2507774775 @default.
- W4291111105 cites W2554115513 @default.
- W4291111105 cites W2559419695 @default.
- W4291111105 cites W2755877600 @default.
- W4291111105 cites W2760467132 @default.
- W4291111105 cites W2768534399 @default.
- W4291111105 cites W2791738263 @default.
- W4291111105 cites W2800324465 @default.
- W4291111105 cites W2811464999 @default.
- W4291111105 cites W2883654650 @default.
- W4291111105 cites W2888469000 @default.
- W4291111105 cites W2909727642 @default.
- W4291111105 cites W2933110746 @default.
- W4291111105 cites W295447163 @default.
- W4291111105 cites W2971628266 @default.
- W4291111105 cites W2974449084 @default.
- W4291111105 cites W2996735769 @default.
- W4291111105 cites W3011381567 @default.
- W4291111105 cites W3021305401 @default.
- W4291111105 cites W3048601937 @default.
- W4291111105 cites W3080366692 @default.
- W4291111105 cites W3082822735 @default.
- W4291111105 cites W3084402305 @default.
- W4291111105 cites W3090201337 @default.
- W4291111105 cites W3091268816 @default.
- W4291111105 cites W3093825786 @default.
- W4291111105 cites W3099722764 @default.
- W4291111105 cites W3129467993 @default.
- W4291111105 cites W3194213440 @default.
- W4291111105 cites W3206141883 @default.
- W4291111105 cites W4206841660 @default.
- W4291111105 cites W4244685317 @default.
- W4291111105 cites W4293247451 @default.
- W4291111105 doi "https://doi.org/10.1016/j.ijbiomac.2022.08.067" @default.
- W4291111105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35970364" @default.
- W4291111105 hasPublicationYear "2022" @default.
- W4291111105 type Work @default.
- W4291111105 citedByCount "3" @default.
- W4291111105 countsByYear W42911111052023 @default.
- W4291111105 crossrefType "journal-article" @default.
- W4291111105 hasAuthorship W4291111105A5004876774 @default.
- W4291111105 hasAuthorship W4291111105A5013392061 @default.
- W4291111105 hasAuthorship W4291111105A5050355037 @default.
- W4291111105 hasAuthorship W4291111105A5052056925 @default.
- W4291111105 hasAuthorship W4291111105A5076807685 @default.
- W4291111105 hasAuthorship W4291111105A5078361080 @default.
- W4291111105 hasAuthorship W4291111105A5080029717 @default.
- W4291111105 hasConcept C121608353 @default.
- W4291111105 hasConcept C126322002 @default.
- W4291111105 hasConcept C134018914 @default.
- W4291111105 hasConcept C150903083 @default.
- W4291111105 hasConcept C162008176 @default.